LTRN - יתרת חוב לטווח ארוך lanternpharma.com

The daily price chart for Lantern Pharma Inc. (LTRN) reflects the dynamics of a company that delegates laboratory testing to external contractors while utilizing its own AI systems for data processing. The business's financial stability, where the indicator stands at 0.00, currently fluctuates due to its dependence on clinical trial results and contracts. A competitive advantage is provided by the RADR platform and unique patents for genetic markers, which enable the restoration of efficacy for legacy oncology drugs.

This indicator aggregates all credit obligations with a maturity of more than one year, allowing for an assessment of financial stability and the extent of the business's dependence on external borrowing. Monitoring the issuer's long-term liabilities demonstrates how Lantern Pharma Inc. (LTRN) balances its debt load with the funding of its RADR AI platform expansion to accelerate clinical trials for the LP-300 drug.